Skip to main content
. 2023 May 2;9(5):e15970. doi: 10.1016/j.heliyon.2023.e15970

Table 2.

Summary of imaging features.

Modality Feature Prevalence
US Hyperechogenicity 100% (16/16)
US Circumscribed 93.8% (15/16)
MRI Signal loss on fat suppression sequence 100% (5/5)
MRI T1 and T2 Heterogeneity 80% (4/5)
CT Fat density 100% (25/25)
CT Circumscribed 88% (22/25)

*US = Ultrasound, CT = Computed Tomography, MRI = Magnetic Resonance Imaging.